Stroke - Pipeline Review, H1 2018

  • ID: 4473293
  • Report
  • 456 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Artelo Biosciences Inc
  • Epigen Biosciences Inc
  • M et P Pharma AG
  • Novartis AG
  • ReNeuron Group Plc
  • MORE
Stroke - Pipeline Review, H1 2018

Summary:

This latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Pipeline Review, H1 2018, provides an overview of the Stroke (Cardiovascular) pipeline landscape.

Stroke is a condition in which the brain cells suddenly die because of a lack of oxygen. Symptoms occur rapidly and usually last a short time, from a few minutes to a couple of hours. The symptoms of a stroke usually appear suddenly. Initially the person may feel sick, and look pale and very unwell. They may complain of a sudden headache. They may have sudden numbness in their face or limbs, particularly down one side of their body. They may appear confused and have trouble talking or understanding what is being said to them. They may have vision problems, and trouble walking or keeping their balance.

Report Highlights:

Pharmaceutical and Healthcare latest pipeline guide Stroke - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Stroke (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Stroke (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Stroke and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 7, 22, 21, 2, 90, 12 and 1 respectively. Similarly, the Universities portfolio in Phase III, Preclinical and Discovery stages comprises 1, 27 and 3 molecules, respectively.

Stroke (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Stroke (Cardiovascular).
  • The pipeline guide reviews pipeline therapeutics for Stroke (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Stroke (Cardiovascular) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Stroke (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Stroke (Cardiovascular)
Reasons to buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Stroke (Cardiovascular).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Stroke (Cardiovascular) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Artelo Biosciences Inc
  • Epigen Biosciences Inc
  • M et P Pharma AG
  • Novartis AG
  • ReNeuron Group Plc
  • MORE
Introduction

Stroke - Overview

Stroke - Therapeutics Development

Stroke - Therapeutics Assessment

Stroke - Companies Involved in Therapeutics Development

Stroke - Drug Profiles

Stroke - Dormant Projects

Stroke - Discontinued Products

Stroke - Product Development Milestones

Appendix

List of Tables:

Number of Products under Development for Stroke, H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products under Development by Universities/Institutes, H1 2018

Products under Development by Companies, H1 2018

Products under Development by Universities/Institutes, H1 2018

Number of Products by Stage and Target, H1 2018

Number of Products by Stage and Mechanism of Action, H1 2018

Number of Products by Stage and Route of Administration, H1 2018

Number of Products by Stage and Molecule Type, H1 2018

Stroke - Pipeline by Acorda Therapeutics Inc, H1 2018

Stroke - Pipeline by Acticor Biotech SAS, H1 2018

Stroke - Pipeline by ActiveSite Pharmaceuticals Inc, H1 2018

Stroke - Pipeline by Addex Therapeutics Ltd, H1 2018

Stroke - Pipeline by Advanced Inhalation Therapies (AIT) Ltd, H1 2018

Stroke - Pipeline by Affibody AB, H1 2018

Stroke - Pipeline by Anavex Life Sciences Corp, H1 2018

Stroke - Pipeline by Angion Biomedica Corp, H1 2018

Stroke - Pipeline by Antoxis Ltd, H1 2018

Stroke - Pipeline by AptaTargets SL, H1 2018

Stroke - Pipeline by ArmaGen Inc, H1 2018

Stroke - Pipeline by Artelo Biosciences Inc, H1 2018

Stroke - Pipeline by ArunA Biomedical Inc, H1 2018

Stroke - Pipeline by AstraZeneca Plc, H1 2018

Stroke - Pipeline by Athersys Inc, H1 2018

Stroke - Pipeline by Biogen Inc, H1 2018

Stroke - Pipeline by Boehringer Ingelheim GmbH, H1 2018

Stroke - Pipeline by Cardax Inc, H1 2018

Stroke - Pipeline by CHA Bio & Diostech Co Ltd, H1 2018

Stroke - Pipeline by Daiichi Sankyo Co Ltd, H1 2018

Stroke - Pipeline by DiaMedica Therapeutics Inc, H1 2018

Stroke - Pipeline by Diffusion Pharmaceuticals Inc, H1 2018

Stroke - Pipeline by Epigen Biosciences Inc, H1 2018

Stroke - Pipeline by Evgen Pharma Plc, H1 2018

Stroke - Pipeline by F. Hoffmann-La Roche Ltd, H1 2018

Stroke - Pipeline by Fina Biotech SL, H1 2018

Stroke - Pipeline by GC Pharma, H1 2018

Stroke - Pipeline by Genervon Biopharmaceuticals LLC, H1 2018

Stroke - Pipeline by Glialogix Inc, H1 2018

Stroke - Pipeline by Glucox Biotech AB, H1 2018

Stroke - Pipeline by Immunwork Inc, H1 2018

Stroke - Pipeline by International Stem Cell Corp, H1 2018

Stroke - Pipeline by Jeil Pharmaceutical Co Ltd, H1 2018

Stroke - Pipeline by JT Pharmaceuticals Inc, H1 2018

Stroke - Pipeline by Les Laboratoires Servier SAS, H1 2018

Stroke - Pipeline by Living Cell Technologies Ltd, H1 2018

Stroke - Pipeline by Lumosa Therapeutics Co Ltd, H1 2018

Stroke - Pipeline by M et P Pharma AG, H1 2018

Stroke - Pipeline by Magnus Life Ltd, H1 2018

Stroke - Pipeline by Mapreg SAS, H1 2018

Stroke - Pipeline by Meridigen Biotech Co Ltd, H1 2018

Stroke - Pipeline by Neuralstem Inc, H1 2018

Stroke - Pipeline by Neuren Pharmaceuticals Ltd, H1 2018

Stroke - Pipeline by Neurofx Inc, H1 2018

Stroke - Pipeline by Neuronax SAS, H1 2018

Stroke - Pipeline by NeuroSearch A/S, H1 2018

Stroke - Pipeline by New World Laboratories Inc, H1 2018

Stroke - Pipeline by NoNO Inc, H1 2018

Stroke - Pipeline by Novartis AG, H1 2018

Stroke - Pipeline by Noxopharm Ltd, H1 2018

Stroke - Pipeline by NuvOx Pharma LLC, H1 2018

Stroke - Pipeline by Omniox Inc, H1 2018

Stroke - Pipeline by Pharmagenesis Inc, H1 2018

Stroke - Pipeline by Pharmaxis Ltd, H1 2018

Stroke - Pipeline by Pharmicell Co Ltd, H1 2018

Stroke - Pipeline by Phoenix Biotechnology Inc, H1 2018

Stroke - Pipeline by PhytoHealth Corp, H1 2018

Stroke - Pipeline by Pluristem Therapeutics Inc, H1 2018

Stroke - Pipeline by RegeneRx Biopharmaceuticals Inc, H1 2018

Stroke - Pipeline by ReNeuron Group Plc, H1 2018

Stroke - Pipeline by Rich Pharmaceuticals Inc, H1 2018

Stroke - Pipeline by Rubicon Biotechnology Inc, H1 2018

Stroke - Pipeline by SanBio Inc, H1 2018

Stroke - Pipeline by Saneron CCEL Therapeutics Inc, H1 2018

Stroke - Pipeline by Savara Inc, H1 2018

Stroke - Pipeline by Shin Poong PharmCo Ltd, H1 2018

Stroke - Pipeline by Simcere Pharmaceutical Group, H1 2018

Stroke - Pipeline by Spectrum Pharmaceuticals Inc, H1 2018

Stroke - Pipeline by Stemedica Cell Technologies Inc, H1 2018

Stroke - Pipeline by SynZyme Technologies LLC, H1 2018

Stroke - Pipeline by TaiGen Biotechnology Co Ltd, H1 2018

Stroke - Pipeline by Tasly Pharmaceutical Group Co Ltd, H1 2018

Stroke - Pipeline by Tenax Therapeutics Inc, H1 2018

Stroke - Pipeline by TikoMed AB, H1 2018

Stroke - Pipeline by Verseon Corp, H1 2018

Stroke - Pipeline by Vicore Pharma AB, H1 2018

Stroke - Pipeline by Virogenomics BioDevelopment Inc, H1 2018

Stroke - Pipeline by WhanIn Pharmaceutical Co Ltd, H1 2018

Stroke - Pipeline by Zocere Inc, H1 2018

Stroke - Dormant Projects, H1 2018

Stroke - Discontinued Products, H1 2018

List of Figures:

Number of Products under Development for Stroke, H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products under Development by Universities/Institutes, H1 2018

Number of Products by Top 10 Targets, H1 2018

Number of Products by Stage and Top 10 Targets, H1 2018

Number of Products by Top 10 Mechanism of Actions, H1 2018

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018

Number of Products by Top 10 Routes of Administration, H1 2018

Number of Products by Stage and Top 10 Routes of Administration, H1 2018

Number of Products by Top 10 Molecule Types, H1 2018

Number of Products by Stage and Top 10 Molecule Types, H1
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Acorda Therapeutics Inc
  • Acticor Biotech SAS
  • ActiveSite Pharmaceuticals Inc
  • Addex Therapeutics Ltd
  • Advanced Inhalation Therapies (AIT) Ltd
  • Affibody AB
  • Anavex Life Sciences Corp
  • Angion Biomedica Corp
  • Antoxis Ltd
  • AptaTargets SL
  • ArmaGen Inc
  • Artelo Biosciences Inc
  • ArunA Biomedical Inc
  • AstraZeneca Plc
  • Athersys Inc
  • Biogen Inc
  • Boehringer Ingelheim GmbH
  • Cardax Inc
  • CHA Bio & Diostech Co Ltd
  • Daiichi Sankyo Co Ltd
  • DiaMedica Therapeutics Inc
  • Diffusion Pharmaceuticals Inc
  • Epigen Biosciences Inc
  • Evgen Pharma Plc
  • F. Hoffmann-La Roche Ltd
  • Fina Biotech SL
  • GC Pharma
  • Genervon Biopharmaceuticals LLC
  • Glialogix Inc
  • Glucox Biotech AB
  • Immunwork Inc
  • International Stem Cell Corp
  • Jeil Pharmaceutical Co Ltd
  • JT Pharmaceuticals Inc
  • Les Laboratoires Servier SAS
  • Living Cell Technologies Ltd
  • Lumosa Therapeutics Co Ltd
  • M et P Pharma AG
  • Magnus Life Ltd
  • Mapreg SAS
  • Meridigen Biotech Co Ltd
  • Neuralstem Inc
  • Neuren Pharmaceuticals Ltd
  • Neurofx Inc
  • Neuronax SAS
  • NeuroSearch A/S
  • New World Laboratories Inc
  • NoNO Inc
  • Novartis AG
  • Noxopharm Ltd
  • NuvOx Pharma LLC
  • Omniox Inc
  • Pharmagenesis Inc
  • Pharmaxis Ltd
  • Pharmicell Co Ltd
  • Phoenix Biotechnology Inc
  • PhytoHealth Corp
  • Pluristem Therapeutics Inc
  • RegeneRx Biopharmaceuticals Inc
  • ReNeuron Group Plc
  • Rich Pharmaceuticals Inc
  • Rubicon Biotechnology Inc
  • SanBio Inc
  • Saneron CCEL Therapeutics Inc
  • Savara Inc
  • Shin Poong PharmCo Ltd
  • Simcere Pharmaceutical Group
  • Spectrum Pharmaceuticals Inc
  • Stemedica Cell Technologies Inc
  • SynZyme Technologies LLC
  • TaiGen Biotechnology Co Ltd
  • Tasly Pharmaceutical Group Co Ltd
  • Tenax Therapeutics Inc
  • TikoMed AB
  • Verseon Corp
  • Vicore Pharma AB
  • Virogenomics BioDevelopment Inc
  • WhanIn Pharmaceutical Co Ltd
  • Zocere Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll